(+)cis-N-Ethyleneamio-N-normetazocine derivatives. Novel and selective σ ligands with antagonist properties

Journal of Medicinal Chemistry

Volumn 41, Issue 10, 1998, Pages 1574-1580

  Ronsisvalle, Giuseppe ^a   Marrazzo, Agostino ^a   Prezzavento, Orazio ^a   Pasquinucci, Lorella ^a   Vittorio, Franco ^a   Pittala, Valeria ^a   Pappalardo, Maria S ^a   Cacciaguerra, Silvia ^b   Spampinato, Santi ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; MUSCARINIC RECEPTOR BLOCKING AGENT; N ALLYLNORMETAZOCINE; N ETHYLENEAMINO N NORMETAZOCINE DERIVATIVE; OPIATE ANTAGONIST; SEROTONIN 2 ANTAGONIST; UNCLASSIFIED DRUG; BENZOMORPHAN DERIVATIVE; DOPAMINE 2 RECEPTOR; LIGAND; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; OPIATE RECEPTOR; SEROTONIN RECEPTOR; SIGMA OPIATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MOUSE; NONHUMAN; RECEPTOR AFFINITY; STEREOTYPY; ANIMAL; BRAIN; CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; GUINEA PIG; METABOLISM; RADIOASSAY; RAT; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; BENZOMORPHANS; BRAIN; GUINEA PIGS; LIGANDS; MALE; MICE; RADIOLIGAND ASSAY; RATS; RECEPTOR, MUSCARINIC M2; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC; RECEPTORS, OPIOID; RECEPTORS, SEROTONIN; RECEPTORS, SIGMA; STEREOISOMERISM; STEREOTYPED BEHAVIOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032492764     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970333f     Document Type: Article

References (54)

1. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; de Costa, B.; Rice, K. C. Sigma Receptors: Biology and Function. Pharmacol. Rev. 1990, 42, 355-402.
2. Kavanaugh, M. P.; Parker, J.; Bobker, D. H.; Keana, J. F.; Weber, E. Solubilization and Characterization of σ-Receptors from Guinea Pig Brain Membranes. J. Neurochem. 1989, 53, 1575-1580.
3. Moebius, F. F.; Burrows, G. G.; Hanner, M.; Schimd, E.; Striessnig., J.; Glossmann, H. Identification of a 27-kDa High Affinity Phenylalkylamine-Binding Polypeptide as the Sigma-1 Binding site by Photoaffnity Labeling and Ligand-Directed Antibodies. J. Mol. Pharmacol. 1993, 44; 966-971.
4. Schuster, D. I.; Ehrlich, G. K.; Murphy, R. B. Purification and Partial Amino Acid Sequence of 28 kDa Cyclophillin-like Component of Rat Liver Sigma Receptor. Life Sci. 1994, 55, PL151-156.
5. Schuster, D. I.; Arnold, F. J.; Murphy, R. B. Purification, Pharmacological Characterization and Photoaffinity Labeling of Sigma Receptors from Rat and Bovine Brain. Brain Res. 1995, 670, 14-28.
6. 1 binding site. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 8072-8077.
7. Hellewell, S. B.; Bowen W. D. A Sigma-like Binding Site in Rat Pheochromocytoina (PC12) Cells: Decreased Affinity for (+)-Benzomorphans and Lower Molecular Weight Suggest a Different Sigma Receptor Form from that of Guinea Pig Brain. Brain Res. 1990, 527, 244-253.
8. Quirion, R.; Bowen, W. D.; Itzhak, Y.; Junien, J. L.; Musacchio, J. M.; Rothman, R. B.; Su, T. P.; Torn, S. W.; Taylor, D. P. A Proposal for the Classification of Sigma Binding Sites. Trends Pharmacol. Sci. 1992, 13, 85-86.
9. 2 Receptors in Motor Function. Eur. J. Pharmacol. 1993, 231, 61-68.
10. Walker, J. M.; Hohmann, A. G.; Hamsteet, M. K.; Martin, W. J.; Beierlein, M.; Roth, J. S.; Patrick, S. L.; Carroll, F. I.; Patrick R. L. Acetylcholine, Sigma Receptors, CCK, and Eicosanoids Neurotoxins. In Aspect of Synaptic Transmission; Stone, T. W., Ed.; Taylor and Francis: London, 1993; Vol. II, pp 91-112.
11. Schoenwald, R. D.; Barfknecht, C. F.; Shirolkar, S.; Xia, E. The Effects of Sigma Ligands on Protein Release from Acinar cells: a Potential Agonist/Antagonist Assay. Life Sci. 1995, 56 (15), 1275-1285.
12. Matsumoto, R. R.; Hemstreet, M. K.; Lai, N. L.; Thurkauf, A.; De Costa, B. R.; Rice, K. C.; Hellewell, S. B.; Bowen, W. D.; Walker, J. M. Drug Specificity of Pharmacological Dystonia. Pharmacol. Biochem. Behav. 1990, 36, 151.
13. 3H]Dopaminergic Releate via a Presinaptic Mecanism. Eur. J. Pharmacol. 1995, 294 (2/3), 713-19.
14. Brent, P. J.; Pang, G. T. Sigma Binding Site Ligands Inhibit Cell Proliferation in Mammary arid Colon Carcinoma Cell Lines and Melanoma Cells in Culture. Eur. J. Pharmacol. 1995, 278 (2), 151-160.
15. Vilner, B. J.; de Costa, B. R.; Bowen, W. D. Cytotoxic Effects of Sigma Ligands: Sigma Receptor-mediated Alterations in Cellular Morphology and Viability. J. Neurosci. 1995, 75 (1), 117-134.
16. Moltzen, E. K.; Perregaard, J.; Meier, E.; Sanchez, C.; Arnt, J.; Nielsen, J. B. Spyrocyclic Isobenzofuran Derivatives; a New Class of High Affinity Sigma Ligands with Potent Anxiolytic Activities. Twelfth International Symposium on Medicinal Chemistry; Basel, Switzerland, 13-17 September 1992, Abstract P-105.A.
17. Debonnel, G.; de Montigny, C. Modulation of NMDA and Dopaminergicrgic Neurotransmission by Sigma Ligands: Possible Implications for the Treatment of Psychiatric Disorders. Life Sci. 1996, 58, 721-734.
18. Hudkins, R. L.; Mailmann, R. B.; DeHaven-Hudkins D. L.; Novel (4-Phenylpiperidinyl)-and (4-Phenylpiperazinyl)alkyl-Spaced Esters of 1-Phenylcyclopentane-carboxylic Acid as Potent σ-Selective Compounds. J. Med. Chem. 1994, 37, 1964-1970.
19. 2 Receptor Subtype. J. Med. Chem. 1995, 38, 4776-4785.
20. Tanaka, M.; Chaki, S.; Imagawa, Y.; Okuyama, S.; Muramatsu, M.; Otomo, S. FH-510, a potent and selective ligand for rat brain σ recognition sites. Eur. J. Pharmacol. 1993, 238, 89-92.
21. 1 recognition site. Eur. J. Pharmacol. 1994, 271, 235-236.
22. 2 receptor affinity and subtype selectivity. Eur. J. Pharmacol. 1995, 278, 257-260.
23. Akunne, H. C.; Whetzel, S. Z.; Wiley, J. N.; Corbin, A. E.; Ninteman, F. W.; Tecle, H.; Pei, Y.; Pugsley, T. A.; Heffner, T. G. The pharmacology of the novel and selective sigma ligand, PD 144418. Neuropharmacology 1997, 36, 51-62.
24. Matsumoto, R. R.; Bowen, W. D.; Tom, A. M.; Vo, V. N.; Truong, D. D.; de Costa, B. R. Characterization of Two Novel Sigma Receptor Ligands: Antidystonic Effects in Rat Suggest Sigma Receptor Antagonism. Eur. J. Pharmacol. 1995, 280, 301-310.
25. Tam, S. W. Potential therapeutic application of sigma receptor antagonists. Sigma Receptors; Itzhak, Y., Ed.; Academic Press: San Diego, CA, 1994; Chapter 7, pp 191-204.
26. 3H]-Haloperidol Binding in Guinea Pig Brain Membranes. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 5618-5621.
27. Largent, B. L.; Wilkstrom, H.; Snowman, A. M.; Snyder, S. H. Novel Antipsychotic Drugs Share High Affinity of Sigma Receptors. Eur. J. Pharmacol. 1988, 155, 345-347.
28. Okuyama, S.; Imagawa, Y.; Ogawa, S.; Araki, H.; Ajima, A.; Tanaka, M.; Muramatsu, M.; Nakazato, A.; Yamaguchi, K.; Yoshida, M.; Otomo, S. NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci. 1993, 53, PL 285-290.
29. Chien, C. C.; Pasternak, G. W. Selective antagonism of opioid analgesia by a sigma system. J. Pharmacol. Exp. Ther. 1994, 271, 1583-1590.
30. 1 system. Eur. J. Pharmacol. 1993, 250, R7-8.
31. 1 receptor. Eur. J. Pharmacol. 1997, 331, R5-6.
32. Martin, W. R.; Eades, C. S.; Thompson, J. A.; Huppler, R. E. The Effects of Morphine and Nalorphine-like Drugsin the non Dependent and Morphine-Dependent Chronic Spinal Dog. J. Pharmacol. Exp. Ther. 1976, 197, 517-532.
33. De Costa, B. R.; He, X.-S. Structure-activity relationships and evolution of sigma receptor ligands (1976-present). Sigma Receptors; Itzhak, Y., Ed.; Academic Press: San Diego, CA, 1994; Chapter 3, pp 45-111.
34. Carroll, F. I.; Abrahm, P.; Parham, K.; Bai, X.; Zhang, X.; Brine, G. A.; Mascarella, S. W.; Martin, B. R.; May, E. L.; Sauss, C.; Di Paolo, L.; Wallace, P.; Walker, J. M.; Bowen, W. D. Enantiomeric N-Substituted N-Normetazocines: a Comparative Study of Affinities at Sigma, PCP, and μ Opioid Receptors. J. Med. Chem. 1992, 35, 2812-2818.
35. Carroll, F. I.; Bai, X.; Zhang, X.; Brine, G. A.; Mascarella, S. W.; Di Paolo, L.; Wallace, P.; Walker, J. M.; Bowen, W. D. Synthesis, Binding (Sigma Site) and Pharmacological Model of N-Substituted N-Normetazocine and N-Nordeoxymetazocine Analogues. Med. Chem. Res. 1992, 2, 3-9.
36. May, E. L.; Aceto, M. D.; Bowman E. R.; Bentley, C.; Martin, B. R.; Harris, L. S.; Medzihradsky, F.; Mattson, V.; Jacobsoc, A. E. Antipodal α-N-(Methyl through Decyl)-N-normetazocines(5,9adimethyl-2′-hydroxy-6,7-benzomorphans): In vitro and in Vivo Properties. J. Med. Chem. 1994, 37, 3408-3418.
37. 1) Site and Quantitative Structure-Affinity Relationship Studies. J. Med. Chem. 1995, 38, 565-569.
38. Danso-Danquah, R.; Bai, X.; Zhang, X.; Mascarella, S. W.; Williams, W.; Sine, B.; Bowen, W. D.; Carroll, F. I. Synthesis and σ Binding Properties of 1′- and 3′-Halo- and 1′,3′-Dihalo-N-Normetazocine Analogues. J. Med. Chem. 1995, 38, 2986-2989.
39. Danso-Danquah, R.; Bai, X.; Zhang, X.; Mascarella, S. W.; Williams, W.; Sine, B.; Bowen, W. D.; Carroll, F. I. Synthesis and Sigma Binding Properties of 2′- Substituted 5,9α-Dimethyl6,7-benzomorphans. J. Med. Chem. 1995, 38, 2978- 2985.
40. Brine G. A.; Berrang, B.; Hayes, J. P.; Carroll, F. I. An Improved Resolution of (±)-cis-N-Normetazocine. J. Heterocycl. Chem. 1990, 27, 2139-2143.
41. Tanaka, M.; Chaki, S.; Imagawa, Y.; Okuyama, S.; Muramatsu, M.; Otomo, S. FH-510, a Potent and Selective Ligand for Rat Brain σ Recognition sites. Eur. J. Pharmacol. 1993, 238, 89-92.
42. De Costa, B. R.; Radesca, L.; Di Paolo, L.; Bowen, W. D Synthesis, Characterization, and Bilogical Evaluation of a Novel class of N-(Arylethyl)-N-alkyl-2-(1-pyrrolidinyl)-ethylamines: Structural Requirements and Binding Affinity at the σ Receptor. J. Med. Chem. 1992, 35, 38-47.
43. Vaupel, D. B.; McCoun, D.; Cone, E. J. Phencyclidine Analogues and Precursors: Rotarod and Lethal Dose Studies in the Mouse. J. Pharmacol. Exp. Ther. 1984, 230, 20-27.
44. Gordon, M.; Lafferty, J. J. Aralkylbenzomorphan derivatives. U.S. Patent, 2,924,603, 1960; Chem. Abstr. 1960, 54, 18556g.
45. Brown, H. C.; Heim, P. Selective reductions. XVIII. The Fast Reaction of Primary, Secondary, and Tertiary Amides with Diborane. A Simple, Convenient Procedure for the Conversion of Amides to the Corresponding Amines. J. Org. Chem. 1973, 5, 912-916.
46. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein Dye-Binding. Anal. Biochem. 1986, 72, 248-274.
47. 3H]-(+)-Pentazocine to Sigma Recognition Site in Guinea Pig Brain. Eur. J. Pharmacol. 1992, 227, 371-378.
48. Mach, R. H.; Smith, C. R.; Childers S. R. Ibogaine Possesses a Selective Affinity for Sigma-2 Receptors, Life Sci. 1995, 57, PL 57-62.
49. Ronsisvalle, G.; Prezzavento, O.; Pasquinucci, L.; Marrazzo, A.; Vittorio, F.; Gomez-Vidal, J. A.; Carboni, L.; Spampinato, S. CCB, a Novel Specific K Opioid Agonist, which Discriminates Between Opioid and Sigma-1 Recognition Sites. Life Sci. 1995, 57, 1487-141495.
50. 3H]-1-[1(2-Thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 1986, 238, 739-748.
51. 3H]-Spiroperidol on Rat Striatal Membranes. Eur. J. Pharmacol. 1978, 50, 283-284.
52. 2 Receptor Antagonist: Receptor Binding, Electrophysiological and Neuropharmacological Profiles. J. Pharmacol. Exp. Ther. 1992, 263, 1167-1174.
53. 3H]-AT-Methylscopolamine Binding to Muscarinic receptors in the Rat Central Nervous System: Evidence for the Existence of Three Classes of Binding Sites. Mol. Pharmacol. 1986, 30, 305-314.
54. McPherson, G. A. Analysis of Radioligand Binding Experiments. A Collection of Computer Programs for the IBM PC, J. Pharmacol. Methods 1985, 14, 213-228.